We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

CRISPR and Genome Editing – Products

Screen Single Cells in Their Own Microenvironment
App Note / Case Study

Screen Single Cells in Their Own Microenvironment

This app note highlights a uniquely protective environment to support cell viability and integrity during incubation and shield cells against shear stress during subsequent analysis.

A PCR Machine.
Product News

Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production

Rapid, sensitive, and validated detection of viral replication genes using droplet digital™ PCR during cell and gene therapy production.
Someone holding a test tube next to a model of DNA.
Product News

N4 Pharma’s Novel Delivery Systems, Nuvec® and LipTide®, Advance Towards Commercialisation

N4 Pharma PLC (AIM: N4P), recently acquired a controlling interest in Nanogenics Limited.
Someone holding a test tube in front of a model of DNA.
Product News

Asimov Launches Lv Edge Packaging System To Optimize Lentivirus Production

New off-the-shelf system reduces the cost and risk of lentiviral (LV) production for cell and gene therapy developers. Single-plasmid transfection minimizes GMP plasmid costs and supply chain risk.
Comprehensive coverage of GMP products in your cell therapy production process
Product
Advertisement

Comprehensive Coverage of GMP Products in Your Cell Therapy Production Process

Integrating our GMP proteins into your manufacturing process has never been easier. With our affordable GMP growth factors, maintain that flexibility to either directly use GMP grade or slowly transition with our 'pre-GMP' premium grade proteins.
Elevating Your Cell and Gene Therapy with High-quality Solutions
Product
Advertisement

Elevating Your Cell and Gene Therapy With High-Quality Solutions

Manufacturing cell therapies and other innovative medicines can be a challenge. Our tools and solutions are designed to work with you from the first step. Want to learn more? Explore our webpage and brochure and find what’s right for you!
Double helix structure of DNA.
Product News

Ers Genomics and StemSight Sign CRISPR/Cas9 License Agreement

License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness.
Double helix structure of DNA.
Product News

Key Charpentier/Doudna CRISPR Patent Upheld by Japanese Patent Office

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced its second Japanese Patent.
Cell Line App note
App Note / Case Study

Overcoming the Hard-to-Transfect Cell Line Hurdle

Enter the era of CRISPR/Cas9 – a game-changer in unraveling life's intricacies. Unleash the potential to manipulate genes, a breakthrough cornerstone in biomedicine and drug discovery.
GMP & RUO Grade iPSC Gene Editing & Differentiation Services
Product
Advertisement

GMP & RUO Grade iPSC Gene Editing & Differentiation Services

Complete iPSC/MSC manufacturing platform: Generate, CRISPR engineer, and differentiate iPSCs into NK cells, T cells, neurons, or cardiomyocytes at Applied StemCell’s new GMP manufacturing facility in Milpitas, California.
Advertisement